← Leaderboards
Brad H Rovin
Ohio State University
$10,724,088
Attributed
$22,814,391
Total exposure
15
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.4M · FY2008–25$2.5M$1.9M$1.3M$625K$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$22,814,391 · 15
By mechanism
R01$8,949,090 · 5
UC2$5,148,251 · 1
U01$3,991,244 · 2
UH3$2,184,131 · 1
R21$1,140,625 · 3
UG3$1,105,158 · 1
Top collaborators
- Pei-Hui Lin8 shared
- Tarek Maurice Ashkar6 shared
- Jill P Buyon6 shared
- Pierre C Dagher6 shared
- Jon B Klein6 shared
- Michelle A Petri6 shared
- Victoria P Werth6 shared
- Haifeng M Wu6 shared
Most similar at Ohio State University
Same institution · by research overlap
- Hua Zhu$6,731,822
- Heather Chandler$2,907,094
- Pei-Hui Lin$2,689,875
- Sylvester M Black$3,213,105
- Haichang Li$905,118
Others in their field
Top investigators on “Kidney”
- Jeffrey P Krischer · University Of South Florida$540,222,210
- John M Lachin · George Washington University$155,894,464
- David M Nathan · Massachusetts Institute Of Technology$127,229,266
- Kathryn Hirst · Caritas St. Elizabeth'S Medical Center$111,521,899
- David Heimbrook · Leidos Biomedical Research, Inc.$83,221,586
- Peter Scott Heeger · Case Western Reserve University$80,562,246
Research focus
KidneyInjuryResponseUrineTissuesKidney DiseasesPhenotypeSystemic Lupus ErythematosusTubular FormationPathologyMonitorProteomicsChronic Kidney FailureMolecularInflammationPathogenesisOrganRenal FunctionLupus NephritisCohortSamplingFutureBaseBiopsy
Grant awards (53)
Lupus Omics Cutaneous Kidney Investigative Team (LOCKIT)$1,249,871
UC2 · FY2025 · AR
Muscle-Kidney Crosstalk in Age-related Kidney Disease$461,093
R01 · FY2025 · AG
Lupus Omics Cutaneous Kidney Investigative Team (LOCKIT)$600,000
UC2 · FY2024 · AR
Muscle-Kidney Crosstalk in Age-related Kidney Disease$470,502
R01 · FY2024 · AG
Lupus Omics Cutaneous Kidney Investigative Team (LOCKIT)$288,149
UC2 · FY2024 · AR
Lupus Omics Cutaneous Kidney Investigative Team (LOCKIT)$1,600,000
UC2 · FY2023 · AR
Lupus Omics Cutaneous Kidney Investigative Team (LOCKIT) - Pain Supplement$356,561
UC2 · FY2023 · AR
Targeting Aberrant Expression of Cytokines/Chemokines for an Inflammatory Nephritis Cure$196,875
R21 · FY2023 · AI
Lupus Omics Cutaneous Kidney Investigative Team (LOCKIT)$1,053,670
UC2 · FY2022 · AR
Predictive Biomarkers for disease activity and organ damage in patients with lupus$582,534
R01 · FY2022 · AR
Muscle-Kidney Crosstalk in Age-related Kidney Disease$470,502
R01 · FY2022 · AG
Targeting Aberrant Expression of Cytokines/Chemokines for an Inflammatory Nephritis Cure$236,250
R21 · FY2022 · AI
Nephron Sub-segmental Omics and Quantitative 3D Imaging of Human Kidney.$679,109
UH3 · FY2021 · DK
Predictive Biomarkers for disease activity and organ damage in patients with lupus$628,779
R01 · FY2021 · AR
Muscle-Kidney Crosstalk in Age-related Kidney Disease$470,502
R01 · FY2021 · AG
Nephron Sub-segmental Omics and Quantitative 3D Imaging of Human Kidney.$825,911
UH3 · FY2020 · DK
Predictive Biomarkers for disease activity and organ damage in patients with lupus$653,985
R01 · FY2020 · AR
Muscle-Kidney Crosstalk in Age-related Kidney Disease$455,940
R01 · FY2020 · AG
Targeting cell membrane repair for treatment of acute kidney injury$422,747
R01 · FY2020 · DK · contact PI
Predictive Biomarkers for disease activity and organ damage in patients with lupus$642,740
R01 · FY2019 · AR
Nephron Sub-segmental Omics and Quantitative 3D Imaging of Human Kidney.$579,111
UH3 · FY2019 · DK
Targeting cell membrane repair for treatment of acute kidney injury$422,747
R01 · FY2019 · DK
Nephron Sub-segmental Omics and Quantitative 3D Imaging of Human Kidney.$100,000
UH3 · FY2019 · DK
Predictive Biomarkers for disease activity and organ damage in patients with lupus$667,800
R01 · FY2018 · AR
Nephron Sub-segmental Omics and Quantitative 3D Imaging of Human Kidney.$579,111
UG3 · FY2018 · DK
Targeting cell membrane repair for treatment of acute kidney injury$530,892
R01 · FY2018 · DK
Targeting cell membrane repair for treatment of acute kidney injury$530,892
R01 · FY2017 · DK
Nephron Sub-segmental Omics and Quantitative 3D Imaging of Human Kidney.$526,047
UG3 · FY2017 · DK
Discovery & Validation of Biomarkers of Kidney Pathology$395,740
U01 · FY2017 · DK · contact PI
Targeting cell membrane repair for treatment of acute kidney injury$544,392
R01 · FY2016 · DK
Discovery & Validation of Biomarkers of Kidney Pathology$395,089
U01 · FY2016 · DK · contact PI
Discovery & Validation of Biomarkers of Kidney Pathology$416,495
U01 · FY2015 · DK · contact PI
Discovery & Validation of Biomarkers of Kidney Pathology$397,601
U01 · FY2014 · DK · contact PI
Discovery & Validation of Biomarkers of Kidney Pathology$417,775
U01 · FY2013 · DK · contact PI
Forecasters of futute and progressive CDK in patients with microvascular glomerul$190,212
U01 · FY2013 · DK · contact PI
Forecasters of futute and progressive CDK in patients with microvascular glomerul$470,289
U01 · FY2012 · DK · contact PI
Forecasters of futute and progressive CDK in patients with microvascular glomerul$445,180
U01 · FY2011 · DK · contact PI
Forecasters of futute and progressive CDK in patients with microvascular glomerul$365,321
U01 · FY2010 · DK · contact PI
Modeling SLE Nephritis Through Urine MCP-1$232,193
R01 · FY2010 · DK · contact PI
Forecasters of futute and progressive CDK in patients with microvascular glomerul$100,000
U01 · FY2010 · DK · contact PI
Forecasters of futute and progressive CDK in patients with microvascular glomerul$397,542
U01 · FY2009 · DK · contact PI
Modeling SLE Nephritis Through Urine MCP-1$234,636
R01 · FY2009 · DK · contact PI
Protein Phenotyping of SLE Nephritis Flare Cycle$187,500
R21 · FY2009 · DK · contact PI
Protein Phenotyping of SLE Nephritis Flare Cycle$225,000
R21 · FY2008 · DK · contact PI
Modeling SLE Nephritis Through Urine MCP-1$202,500
R01 · FY2008 · DK · contact PI
Proteomic and mRNA Profiling of Urine and Urine Sediment$147,500
R21 · FY2004 · DK
Proteomic and mRNA Profiling of Urine and Urine Sediment$147,500
R21 · FY2003 · DK
Chemokine regulation in human SLE nephritis$295,892
P01 · FY2002 · DK
CHEMOKINE REGULATION IN IMMUNE COMPLEX RENAL DISEASE$111,835
R01 · FY2001 · DK
Chemokine regulation in human SLE nephritis$0
P01 · FY2001 · DK
CHEMOKINE REGULATION IN IMMUNE COMPLEX RENAL DISEASE$211,879
R01 · FY2000 · DK
EFFECT OF H5G1.1 MONOCLONAL ANTIBODY ON REDUCTION OF PROTEINURIA IN PATIENTS$0
M01 · FY2000 · RR
EFFECT OF H5G1.1 MONOCLONAL ANTIBODY ON REDUCTION OF PROTEINURIA IN PATIENTS$0
M01 · FY2000 · RR